Habtamu A Betelle

Array ( [id] => 1356727 [patent_doc_number] => 06569403 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-05-27 [patent_title] => 'Determining effects of external stimuli on the brain using PET' [patent_app_type] => B1 [patent_app_number] => 09/551330 [patent_app_country] => US [patent_app_date] => 2000-04-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6090 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 139 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/569/06569403.pdf [firstpage_image] =>[orig_patent_app_number] => 09551330 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6381772 [patent_doc_number] => 20020119989 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-29 [patent_title] => 'Chemical compounds having ion channel blocking activity for the treatment of immune dysfunction' [patent_app_type] => new [patent_app_number] => 09/550645 [patent_app_country] => US [patent_app_date] => 2000-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8769 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0119/20020119989.pdf [firstpage_image] =>[orig_patent_app_number] => 09550645 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4249338 [patent_doc_number] => 06221883 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-04-24 [patent_title] => 'Method of dopamine inhibition using l-threo-methylphenidate' [patent_app_type] => 1 [patent_app_number] => 9/547767 [patent_app_country] => US [patent_app_date] => 2000-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 1476 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/221/06221883.pdf [firstpage_image] =>[orig_patent_app_number] => 547767 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1595233 [patent_doc_number] => 06384037 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-05-07 [patent_title] => 'R-hydroxynefazodone' [patent_app_type] => B1 [patent_app_number] => 09/545602 [patent_app_country] => US [patent_app_date] => 2000-04-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4825 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/384/06384037.pdf [firstpage_image] =>[orig_patent_app_number] => 09545602 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6082457 [patent_doc_number] => 20020082240 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-06-27 [patent_title] => 'METHOD FOR TREATING RESTENOSIS WITH A2A ADENOSINE RECEPTOR AGONISTS' [patent_app_type] => new [patent_app_number] => 09/543385 [patent_app_country] => US [patent_app_date] => 2000-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 8015 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20020082240.pdf [firstpage_image] =>[orig_patent_app_number] => 09543385 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7079223 [patent_doc_number] => 20010041745 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-11-15 [patent_title] => 'Methods for increasing levels of acetylcholine' [patent_app_type] => new [patent_app_number] => 09/537426 [patent_app_country] => US [patent_app_date] => 2000-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3397 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0041/20010041745.pdf [firstpage_image] =>[orig_patent_app_number] => 09537426 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4353281 [patent_doc_number] => 06291490 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-09-18 [patent_title] => 'Methods and compositions for treating conditions caused by excessive calcium influx in cells using optically pure (-) amlodipine' [patent_app_type] => 1 [patent_app_number] => 9/523733 [patent_app_country] => US [patent_app_date] => 2000-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7038 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/291/06291490.pdf [firstpage_image] =>[orig_patent_app_number] => 523733 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4320180 [patent_doc_number] => 06248728 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-06-19 [patent_title] => 'Phosphatidylcholine compositions and methods for lowering intestinal absorption and plasma levels of cholesterol' [patent_app_type] => 1 [patent_app_number] => 9/523042 [patent_app_country] => US [patent_app_date] => 2000-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 7 [patent_no_of_words] => 3251 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 124 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/248/06248728.pdf [firstpage_image] =>[orig_patent_app_number] => 523042 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1495750 [patent_doc_number] => 06403651 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-06-11 [patent_title] => 'Mediation of circadian rhythms' [patent_app_type] => B1 [patent_app_number] => 09/402024 [patent_app_country] => US [patent_app_date] => 2000-03-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 12 [patent_no_of_words] => 4650 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/403/06403651.pdf [firstpage_image] =>[orig_patent_app_number] => 09402024 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4380234 [patent_doc_number] => 06303610 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-10-16 [patent_title] => 'Method of treating gout with certain indole compounds' [patent_app_type] => 1 [patent_app_number] => 9/462346 [patent_app_country] => US [patent_app_date] => 2000-03-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10787 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 938 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/303/06303610.pdf [firstpage_image] =>[orig_patent_app_number] => 462346 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4339025 [patent_doc_number] => 06284274 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-09-04 [patent_title] => 'Analgesic tablet compositions' [patent_app_type] => 1 [patent_app_number] => 9/518584 [patent_app_country] => US [patent_app_date] => 2000-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6054 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 101 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/284/06284274.pdf [firstpage_image] =>[orig_patent_app_number] => 518584 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4312510 [patent_doc_number] => 06316469 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-11-13 [patent_title] => 'Use of selective serotonin reuptake inhibitors for treatment of chest pain of non-cardiac origin and gastro-esophageal reflux disease' [patent_app_type] => 1 [patent_app_number] => 9/516961 [patent_app_country] => US [patent_app_date] => 2000-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4828 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 81 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/316/06316469.pdf [firstpage_image] =>[orig_patent_app_number] => 516961 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1494550 [patent_doc_number] => 06342496 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-01-29 [patent_title] => 'Bupropion metabolites and methods of use' [patent_app_type] => B1 [patent_app_number] => 09/510241 [patent_app_country] => US [patent_app_date] => 2000-02-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11292 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/342/06342496.pdf [firstpage_image] =>[orig_patent_app_number] => 09510241 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6901671 [patent_doc_number] => 20010023254 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-09-20 [patent_title] => 'Use of sulfamate derivatives for treating impulse control disorders' [patent_app_type] => new [patent_app_number] => 09/506991 [patent_app_country] => US [patent_app_date] => 2000-02-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5544 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0023/20010023254.pdf [firstpage_image] =>[orig_patent_app_number] => 09506991 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6721393 [patent_doc_number] => 20030055083 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-20 [patent_title] => 'Method of providing an antihistaminic effect in a hepatically impaired patient' [patent_app_type] => new [patent_app_number] => 09/502331 [patent_app_country] => US [patent_app_date] => 2000-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2115 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0055/20030055083.pdf [firstpage_image] =>[orig_patent_app_number] => 09502331 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4296418 [patent_doc_number] => 06184251 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-02-06 [patent_title] => 'Use of arachidonic acid and/or docosahexanoic acid for the treatment of dyspraxia' [patent_app_type] => 1 [patent_app_number] => 9/254074 [patent_app_country] => US [patent_app_date] => 2000-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2432 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/184/06184251.pdf [firstpage_image] =>[orig_patent_app_number] => 254074 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1545806 [patent_doc_number] => 06444665 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-09-03 [patent_title] => 'Method for treating pain' [patent_app_type] => B1 [patent_app_number] => 09/498047 [patent_app_country] => US [patent_app_date] => 2000-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4178 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/444/06444665.pdf [firstpage_image] =>[orig_patent_app_number] => 09498047 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1595491 [patent_doc_number] => 06384077 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-05-07 [patent_title] => 'Highly purified EPA for treatment of schizophrenia and related disorders' [patent_app_type] => B1 [patent_app_number] => 09/492741 [patent_app_country] => US [patent_app_date] => 2000-01-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 10284 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/384/06384077.pdf [firstpage_image] =>[orig_patent_app_number] => 09492741 [rel_patent_id] =>[rel_patent_doc_number] =>)